• FDA Center Chooses New Product Vigilance Software

    Sep 17, 2013, 12:00 PM by Michael Croft
    Bio-IT World News Brief | November Research Group’s PRIMO software platform has been selected as the new product vigilance software solution for the United States Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH).
    Full story
  • Grants for Newborn Genomic Sequencing

    Sep 17, 2013, 08:00 AM by Michael Croft
    Healio | Four groups have been awarded $5 million grants under the Genomic Sequencing and Newborn Screening Disorders research program.
    Full story
  • DNAnexus Launches NGS Platform-as-a-Service

    Sep 17, 2013, 08:00 AM by Michael Croft
    Bio-IT World News Brief | DNAnexus has launched a specialized platform-as-a-service (PaaS) designed to eliminate the common challenges and costs that enterprises face when building clinically compliant analysis pipelines for next-generation sequencing (NGS) data.  DNAnexus provides a configurable API-based platform that enables clinical testing labs to efficiently move their analysis pipelines into the cloud, using their own algorithms alongside industry-recognized tools and resources to create customized workflows in a secure and compliant environment.
    Full story
  • Complete Genomics Names SVP, General Counsel

    Sep 17, 2013, 07:00 AM by Michael Croft
    Bio-IT World News Brief | Complete Genomics has appointed Ethan Knowlden as senior vice president, general counsel, and secretary of the company, now a wholly-owned subsidiary of BGI-Shenzhen.
    Full story
  • Needed: International DNA Identification Group

    Sep 16, 2013, 14:00 PM by Michael Croft
    NPR | Forensic scientists are calling for the creation of an international group to conduct DNA-identification on remains found after disasters or wars.
    Full story
  • tranSMART Foundation Releases v1.1

    Sep 16, 2013, 12:00 PM by Michael Croft
    Bio-IT World | The tranSMART Foundation today released tranSMART version 1.1. Originally developed as an internal project by Johnson & Johnson, this new version of the cloud-based data sharing solution eliminates the need for user organizations to purchase commercial software and integrates significant new contributions by the developer community over the past year into one new release.
    Full story
  • BGI Davis Opens

    Sep 13, 2013, 07:00 AM by Michael Croft
    Sacramento News 10 | The University of California, Davis is putting the finishing touches on BGI Davis--home for the university's collaboration with BGI. The lab will house 20 sequencers.
    Full story
  • Cubist Completes Purchase of Trius

    Sep 12, 2013, 10:00 AM by Michael Croft
    Bio-IT World Roundup | Cubist Pharmaceuticals has completed a $704 million acquisition of Trius Therapeutics.
    Full story
  • Evotec, Harvard Stem Cell Institute Launch ALS Partnership

    Sep 12, 2013, 09:00 AM by Michael Croft
    Bio-IT World | Evotec and the Harvard Stem Cell Institute (HSCI) launched a strategic partnership to identify compounds that prevent or slow the loss of motor neurons, which is characteristic of the human disease amyotrophic lateral sclerosis (ALS). The collaboration is called CureMN (CureMotorNeuron).
    Full story
  • Data Storage Checklist

    Sep 12, 2013, 06:00 AM by Michael Croft
    Computerworld | Data storage is an ever present question and concern for many companies. Computerworld breaks out 14 points to consider as you build a data storage plan.
    Full story
  • Harvard, MIT Get NSF Grant for Artificial Intelligence Research

    Sep 11, 2013, 12:00 PM by Michael Croft
    Computerworld | Harvard and MIT have been awarded $25 million in NSF grant money to work on artificial intelligence. Researchers will study how the brain creates intelligence and how that process can be replicated in machines.
    Full story
  • Bayer, Broad Sign Oncogenomics Partnership

    Sep 10, 2013, 16:00 PM by Michael Croft
    Bio-IT World  | Bayer HealthCare and the Broad Institute have announced a strategic alliance in oncogenomics and drug discovery in order to jointly discover and develop therapeutic agents that selectively target cancer genome alterations over a period of five years.
    Full story
  • Chemistry Compendium

    Sep 10, 2013, 15:00 PM by Michael Croft
    Chemical & Engineering News | As part of its 90th Anniversary issue, Chemical & Engineering News highlighted nine areas of chemistry that had a profound effect on the planet including antibiotics, computational chemistry, and structural biology.
    Full story
  • Amicus, Biogen Sign Deal for Parkinson's Disease

    Sep 10, 2013, 13:00 PM by Michael Croft
    Xconomy | Amicus Therapeutics and Biogen Idec announced a deal today to discover, develop and commercialize small molecule drugs for Parkinson's Disease.
    Full story
  • Isis and Biogen Sign Six Year Collaboration

    Sep 9, 2013, 14:00 PM by Michael Croft
    Bloomberg Businessweek | Isis Pharmaceuticals signed a six-year agreement with Biogen Idec to develop new therapies to treat neurological disorders.
    Full story
  • Lasker Awards to Five Scientists, Bill and Melinda Gates

    Sep 9, 2013, 13:00 PM by Michael Croft
    New York Times | The Albert and Mary Lasker Foundation awards were announced today. Winners include three scientists who helped deaf people to hear, two for their work in neurotransmission, and Bill and Melinda Gates for their public service work.
    Full story
  • Right to Ignorance

    Sep 6, 2013, 08:00 AM by Michael Croft
    New Scientist | Do we have the right to ignorance? Opinions have been swirling around the disclosure aspect of genetic data, and an article in New Scientist argues that we have the right to choose ignorance.
    Full story
  • Natera, Illumina Renew Prenatal Diagnostics Partnership

    Sep 5, 2013, 09:00 AM by Michael Croft
    Bio-IT World | Natera and Illumina entered a three-year agreement yesterday dictating that Illumina will supply Natera with the HiSeq 2500 sequencing system and associated consumables for Natera’s Panorama noninvasive prenatal test (NIPT).
    Full story
  • ImClone's Sam Waksal has IPO Plans

    Sep 4, 2013, 06:00 AM by Michael Croft
    Bloomberg | ImClone's Sam Waksal is making biotech plans again. Hoping to cash in on biotech's current success, Waksal is planning to spin out two units of his Kadmon Corp.
    Full story
  • Protein Sound and Light Show

    Sep 4, 2013, 06:00 AM by Michael Croft
    Scientific American | Researchers at the University of Chicago have built the first biotech musical instrument. The instrument relies on proteins from plants that respond to sunlight.
    Full story